Clinical Discovery6 min read
The Peptide Revolution: Retatrutide
Why triple agonism may represent the next frontier in obesity pharmacotherapy.
Read articleSeptember 2026 · Issue 01
Medicine, Reimagined.
Evidence. Innovation. Impact. A physician-first issue on the science and tools reshaping care.
Featured articles
Highlights from this issue
Interesting Medicines6 min read
Inclisiran & Evolocumab: Different Paths, Same Goal
Two PCSK9-directed strategies, different mechanisms, and different levels of cardiovascular outcomes evidence.
Read article
Practice Changer7 min read
Stage 1 Hypertension: Treat Early, Treat Smart
A stepwise pathway from accurate diagnosis to risk-based treatment and follow-up.
Read articleDigital edition
11 articlesInside Issue 01
Cover Feature7 min read
Medicine, Reimagined
Fifteen developments changing clinical medicine in 2026 - and what deserves a physician's attention now.
Read articleClinical Discovery6 min read
The Peptide Revolution: Retatrutide
Why triple agonism may represent the next frontier in obesity pharmacotherapy.
Read article
Drug of the Month5 min read
Dapagliflozin Beyond Glycemic Control
A practical view of broad cardiorenal benefits across heart failure and chronic kidney disease.
Read articleInteresting Medicines6 min read
Inclisiran & Evolocumab: Different Paths, Same Goal
Two PCSK9-directed strategies, different mechanisms, and different levels of cardiovascular outcomes evidence.
Read article
Therapeutic Review6 min read
ELEVATE: A Deep Dive
Phase 3 evidence for adjuvant ensartinib after complete resection of ALK-positive NSCLC.
Read article
Clinical Discovery5 min read
Beyond BMI: A More Complete View of Obesity
Move from size alone toward adiposity, fat distribution, function, and health impact.
Read articlePractice Changer7 min read
Stage 1 Hypertension: Treat Early, Treat Smart
A stepwise pathway from accurate diagnosis to risk-based treatment and follow-up.
Read article
Future Medicine5 min read
Lipids Reimagined
Move beyond LDL-C alone toward individualized, risk-based prevention.
Read article
Practice Changer6 min read
Type 2 Diabetes in 2026
Treat the patient - not just the A1C - with an outcomes-first, person-centered pathway.
Read article
Tech Check4 min read
Your Watch Found AF. Now What?
A wearable alert is a starting point - not a diagnosis.
Read article
Tech Check4 min read
How Much Can You Trust Smartwatch Blood Pressure?
Useful for signals and trends; insufficient as the default basis for diagnosis or treatment decisions.
Read article